Synoste
Espoo
About Synoste
Synoste is a Finnish startup company that develops and will sell novel patient friendly medical solutions for treatment of skeletal deformities. The first target is a better device for the well known, but complication prone limb lengthening procedure, which is still extremely uncomfortable for the patient. Synoste utilizes smart materials and introduces a less painful and precisely controllable treatment device that lowers the complication rate and enables faster recovery to normal life.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $11.8M
- Funding stage: M&A
- Last round: Series Unknown (Oct 2018)
- Website: synoste.com
- Phone: +358451796300
Industries & Categories
Biotechnology, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/synoste-26211 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.